Lu Li
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer Cells and Metastasis
- CAR-T cell therapy research
Papers in
- Oncology 37
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 7
- Pancreatic and Hepatic Oncology Research 7
- Lung Cancer Research Studies 5
-
- Cancer Genomics and Diagnostics 8
- Co-authors
- Bert Vogelstein (7 shared papers)Cristian Tomasetti (6 shared papers)Timothy J. Yeatman (2 shared papers)Santo V. Nicosia (2 shared papers)Domenico Coppola (2 shared papers)Richard C. Karl (2 shared papers)Linda Mora (1 shared paper)Ardeshir Hakam (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Frontiers in Oncology (2 papers)Cancer Cell International (2 papers)Blood (2 papers)American Journal of Hematology (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lu Li
67 papers receiving 1.8k citations
Lu Li's Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 489
- Oncology 619
- Molecular Biology 766
- Otorhinolaryngology 43
- Pathology and Forensic Medicine 173
Countries citing papers authored by Lu Li
This map shows the geographic impact of Lu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Li more than expected).
Fields of papers citing papers by Lu Li
This network shows the impact of papers produced by Lu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Li. The network helps show where Lu Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention Hit paper breakdown → | 2017 | 663 |
| 2 | 1999 | 194 | |
| 3 | 2023 | 73 | |
| 4 | Protective influence of lactoferrin on mice infected with the polycythemia-inducing strain of Friend virus complex. | 1987 | 68 |
| 5 | 2021 | 62 | |
| 6 | 2022 | 56 | |
| 7 | 1998 | 54 | |
| 8 | 2021 | 41 | |
| 9 | 2021 | 34 | |
| 10 | 2016 | 34 | |
| 11 | 2016 | 32 | |
| 12 | 1997 | 31 | |
| 13 | 2019 | 30 | |
| 14 | 2018 | 27 | |
| 15 | 2018 | 26 | |
| 16 | 2006 | 21 | |
| 17 | 2023 | 20 | |
| 18 | 2017 | 19 | |
| 19 | 2018 | 19 | |
| 20 | 2009 | 18 |
About Lu Li
Lu Li is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 73 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Multiple Myeloma Research and Treatments (7 papers), CAR-T cell therapy research (7 papers), Pancreatic and Hepatic Oncology Research (7 papers), Genetic factors in colorectal cancer (5 papers), Lung Cancer Research Studies (5 papers) and Biosimilars and Bioanalytical Methods (4 papers). The work is most often cited by research in Cancer Research (489 citations), Oncology (619 citations), Molecular Biology (766 citations), Otorhinolaryngology (43 citations) and Pathology and Forensic Medicine (173 citations). Lu Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Bert Vogelstein, Cristian Tomasetti, Timothy J. Yeatman, Santo V. Nicosia, Domenico Coppola, Richard C. Karl, Linda Mora, Ardeshir Hakam, Giao Hangoc and Li T. Chen. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Cancer Cell International, Blood and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.